Business / Finance

RSS

Quotient Clinical acquires second GMP manufacturing facility, expands pharmaceutical sciences capabilities

Quotient Clinical, the Translational Pharmaceutics Company, has announced a significant expansion of its pharmaceutical sciences capabilities, doubling capacity through the acquisition of a second GMP manufacturing facility and the construction of new formulation development and pharmaceutical analysis laboratories.

14 Jul 2015

OphthaliX updates website to reflect proposed acquisition of Israel-based Improved Vision Systems

OphthaliX Inc., a clinical-stage company focused on developing products that treat and improve sight for people living with ophthalmic disorders, and a subsidiary of Can-Fite BioPharma Ltd., announced today it has launched an updated website, www.ophthaliX.com, to reflect its definitive agreement to acquire Israel-based Improved Vision Systems Ltd.

14 Jul 2015

Medgen starts shipping countertop display cases of SNORenz and SNORenz Night Time to retail stores

Medgen, Inc. today announced that it has started to ship countertop display cases of SNORenz and SNORenz Night Time to retail stores as per the terms of the company's distribution contract with retail distribution giant, Mr. Checkout.

13 Jul 2015

Turtle Beach, Audiology Management Group partner for HyperSound Clear hearing solutions product

Turtle Beach Corporation, the leading-edge audio technology company, today announced a new partnership with Audiology Management Group, Inc. for HyperSound Clear, the Company's groundbreaking hearing healthcare product planned to launch later this year.

13 Jul 2015

ANI acquires 22 previously marketed generic drug products for $25 million from Teva Pharmaceuticals

ANI Pharmaceuticals, Inc. today announced that it has acquired 22 previously marketed generic drug products from Teva Pharmaceuticals for $25 million in cash and a percentage of future gross profits from product sales. The acquisition includes 19 solid-oral dosage products, and 3 oral suspension products.

13 Jul 2015

Smith & Nephew to distribute Scopis TGS Target Guided Surgery system in the UK, Ireland and Belgium

Smith & Nephew plc, the global medical technology business, today announces a partnership with ScopisGmbH, the German developer and manufacturer of surgical navigation systems, as the exclusive distributor of Scopis TGS Target Guided Surgery system in the UK, Ireland and Belgium from 1 July.

13 Jul 2015

Accuray, RaySearch sign long-term collaboration agreement for RayCare oncology information system

Accuray Incorporated and RaySearch Laboratories AB (publ) announced today they have signed a long-term collaboration agreement which will allow Accuray to co-market and offer the RayCare oncology information system (OIS) which is currently in development at RaySearch.

13 Jul 2015

Edwards Lifesciences agrees to acquire CardiAQ Valve Technologies

Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, today announced that it has agreed to acquire CardiAQ Valve Technologies, Inc., a privately held company and developer of a transcatheter mitral valve replacement system.

11 Jul 2015

Tillotts Pharma to purchase global rights for AstraZeneca’s Entocort excluding the U.S.

Tillotts Pharma AG, part of the Zeria Group, announced today that it has entered into an agreement for the acquisition of the global rights for Entocort (budesonide) from AstraZeneca, excluding the U.S., which will remain with AstraZeneca.

9 Jul 2015

Isis Innovation, Ludwig Cancer Research announce launch of new cancer immunotherapy spinout

Isis Innovation, the University of Oxford's technology commercialisation company, and Ludwig Cancer Research are proud to announce the launch of a new spinout company, iOx Therapeutics. iOx Therapeutics will develop a novel cancer immunotherapy discovered through a collaboration between Ludwig Cancer Research and Professor Vincenzo Cerundolo, the director of the MRC Human Immunology Unit within the University of Oxford's Weatherall Institute of Molecular Medicine.

9 Jul 2015

Globavir agrees to exclusively license novel oncology compound to Sorrento Therapeutics

Globavir Biosciences, Inc., a specialty biotechnology company developing small molecule drugs to treat cancer and infectious diseases, and Sorrento Therapeutics, Inc., an oncology company developing new treatments for cancer and associated pain, announced today that the companies have entered into an agreement under which Globavir exclusively licensed its novel oncology compound, BC001, to Sorrento Therapeutics.

9 Jul 2015

Sorrento, NantBioScience form joint venture to develop targeted therapies against cancer

Sorrento Therapeutics, Inc. and NantBioScience, Inc., a majority owned subsidiary of NantWorks, LLC, announced today that they have established a joint venture to focus on the development of 'first-in-class' small molecules against targets that have eluded the pharmaceutical industry to date and which may address important drivers of cancer growth including cancer stem cells.

9 Jul 2015

EvoRx Technologies, AstraZeneca successfully complete research collaboration

AstraZeneca and EvoRx Technologies successfully completed a one-year research collaboration leveraging EvoRx's proprietary Evo-Link technology to discover cell penetrating peptides for a high value intracellular protein–protein interaction target in the respiratory portfolio.

9 Jul 2015

Galmed signs License Agreement for development of blood-based companion diagnostic tool

Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral therapy for the treatment of liver diseases, announced today that it has entered into a Research, Option and License Agreement ("License Agreement") and a Share Purchase Agreement with One Way Liver Genomics S.L., for the development of a non-invasive, blood-based companion diagnostic tool.

8 Jul 2015

Resverlogix and Hepalink close license agreement, sign definitive stock purchase agreement

Resverlogix Corp. announced today that it has closed a license agreement and formally entered into a definitive stock purchase agreement with Shenzhen Hepalink Pharmaceutical Co., Ltd..

8 Jul 2015

Immune Pharmaceuticals amends licensing agreement with Endo Pharmaceuticals

Immune Pharmaceuticals, Inc. announced today that it has amended its 2003 Licensing Agreement with Endo Pharmaceuticals Inc., a subsidiary of Endo International plc. As a result, Immune will transfer to Endo its previously licensed patents related to the use of topical lidocaine in acute and chronic back pain and Endo will grant Immune a royalty-free, non-exclusive, fully transferable license to those patents.

8 Jul 2015

Smith & Nephew becomes exclusive distributor of Scopis TGS system in UK, Ireland and Belgium

8 Jul 2015

NCC of South Korea, Velos agree to expand use of Velos eResearch for cancer research

The National Cancer Center of South Korea and Velos, Inc. have entered into a seven year agreement to expand the use of Velos eResearch for cancer research nationally throughout South Korea and internationally in collaboration with other research partners.

7 Jul 2015

Aytu BioScience now trading under new symbol following its corporate name change

Aytu BioScience, Inc., a specialty healthcare company focused on developing treatments for urological and related conditions, announced today that the company is now trading under the new symbol "AYTU," following its corporate name change, which became effective June 8, 2015.

7 Jul 2015

EnteroMedics prices previously announced public offering of 32,000,000 units

EnteroMedics Inc., a developer and manufacturer of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders, announced the pricing of its previously announced public offering of 32,000,000 units.

7 Jul 2015

Business / Finance

Quotient Clinical acquires second GMP manufacturing facility, expands pharmaceutical sciences capabilities

OphthaliX updates website to reflect proposed acquisition of Israel-based Improved Vision Systems

Medgen starts shipping countertop display cases of SNORenz and SNORenz Night Time to retail stores

Turtle Beach, Audiology Management Group partner for HyperSound Clear hearing solutions product

ANI acquires 22 previously marketed generic drug products for $25 million from Teva Pharmaceuticals

Smith & Nephew to distribute Scopis TGS Target Guided Surgery system in the UK, Ireland and Belgium

Accuray, RaySearch sign long-term collaboration agreement for RayCare oncology information system

Edwards Lifesciences agrees to acquire CardiAQ Valve Technologies

Tillotts Pharma to purchase global rights for AstraZeneca’s Entocort excluding the U.S.

Isis Innovation, Ludwig Cancer Research announce launch of new cancer immunotherapy spinout

Globavir agrees to exclusively license novel oncology compound to Sorrento Therapeutics

Sorrento, NantBioScience form joint venture to develop targeted therapies against cancer

EvoRx Technologies, AstraZeneca successfully complete research collaboration

Galmed signs License Agreement for development of blood-based companion diagnostic tool

Resverlogix and Hepalink close license agreement, sign definitive stock purchase agreement

Immune Pharmaceuticals amends licensing agreement with Endo Pharmaceuticals

Smith & Nephew becomes exclusive distributor of Scopis TGS system in UK, Ireland and Belgium

NCC of South Korea, Velos agree to expand use of Velos eResearch for cancer research

Aytu BioScience now trading under new symbol following its corporate name change

EnteroMedics prices previously announced public offering of 32,000,000 units

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Latest News